Dr. Boucher specializes in the care of immunocompromised patients, transplant-related infections, and S. aureus/MRSA infections. Her research focuses on antibiotic development, advocating for increased development of medicines to treat antibiotic-resistant diseases. She is director of the Infectious Diseases Fellowship Program and staff physician in the Division of Geographic Medicine and Infectious Diseases at Tufts Medical Center and Associate Professor of Medicine at Tufts University School of Medicine. Dr. Boucher is a member of the Board of Directors for the Infectious Diseases Society of America and the American Board of Internal Medicine Subspecialty Board on Infectious Disease. She has authored or coauthored numerous abstracts, chapters and peer-reviewed articles, which have been published in The New England Journal of Medicine, Antimicrobial Agents and Chemotherapy, Clinical Infectious Diseases, and Drugs. Dr. Boucher is a member of several professional organizations, including the Infectious Diseases Society of America, the American Society for Microbiology, and the American Medical Association. She has been included in Best Doctors in America since 2009, and she was selected Fellow and Member of the Board of Directors of the Infectious Diseases Society of America. Dr. Boucher was appointed Associate Editor of Antimicrobial Agents and Chemotherapy to the Infectious Diseases Recruitment Task Force of the Infectious Diseases Society of America, and the ICAAC Program Committee. Dr. Boucher received her M.D. from University of Texas Medical School at Houston; Beth Israel Deaconess Medical Center. Dr. Boucher specializes in the care of immunocompromised patients, transplant-related infections, and S. aureus/MRSA infections. Her research focuses on antibiotic development, advocating for increased development of medicines to treat antibiotic-resistant diseases. She is director of the Infectious Diseases Fellowship Program and staff physician in the Division of Geographic Medicine and Infectious Diseases at Tufts Medical Center and Associate Professor of Medicine at Tufts University School of Medicine. Dr. Boucher is a member of the Board of Directors for the Infectious Diseases Society of America and the American Board of Internal Medicine Subspecialty Board on Infectious Disease. She has authored or coauthored numerous abstracts, chapters and peer-reviewed articles, which have been published in The New England Journal of Medicine, Antimicrobial Agents and Chemotherapy, Clinical Infectious Diseases, and Drugs. Dr. Boucher is a member of several professional organizations, including the Infectious Diseases Society of America, the American Society for Microbiology, and the American Medical Association. She has been included in Best Doctors in America since 2009, and she was selected Fellow and Member of the Board of Directors of the Infectious Diseases Society of America. Dr. Boucher was appointed Associate Editor of Antimicrobial Agents and Chemotherapy to the Infectious Diseases Recruitment Task Force of the Infectious Diseases Society of America, and the ICAAC Program Committee. Dr. Boucher received her M.D. from University of Texas Medical School at Houston; Beth Israel Deaconess Medical Center.

 antibiotic development